- Home
- ALLR vs DKI Comparison
ALLR vs DKI Comparison
Compare ALLR & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- DKI
- Stock Information
- Founded
- ALLR 2004
- DKI 2018
- Country
- ALLR United States
- DKI Hong Kong
- Employees
- ALLR N/A
- DKI N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- DKI
- Sector
- ALLR Health Care
- DKI
- Exchange
- ALLR Nasdaq
- DKI Nasdaq
- Market Cap
- ALLR 15.8M
- DKI 19.0M
- IPO Year
- ALLR N/A
- DKI 2025
- Fundamental
- Price
- ALLR $1.73
- DKI $0.88
- Analyst Decision
- ALLR Strong Buy
- DKI
- Analyst Count
- ALLR 1
- DKI 0
- Target Price
- ALLR $9.25
- DKI N/A
- AVG Volume (30 Days)
- ALLR 641.5K
- DKI 3.2M
- Earning Date
- ALLR 11-13-2025
- DKI 01-01-0001
- Dividend Yield
- ALLR N/A
- DKI N/A
- EPS Growth
- ALLR N/A
- DKI N/A
- EPS
- ALLR N/A
- DKI 26.19
- Revenue
- ALLR N/A
- DKI $10,204,329.00
- Revenue This Year
- ALLR N/A
- DKI N/A
- Revenue Next Year
- ALLR N/A
- DKI N/A
- P/E Ratio
- ALLR N/A
- DKI $0.04
- Revenue Growth
- ALLR N/A
- DKI 100.46
- 52 Week Low
- ALLR $0.61
- DKI $0.80
- 52 Week High
- ALLR $2.35
- DKI $15.00
- Technical
- Relative Strength Index (RSI)
- ALLR 58.71
- DKI N/A
- Support Level
- ALLR $1.54
- DKI N/A
- Resistance Level
- ALLR $1.65
- DKI N/A
- Average True Range (ATR)
- ALLR 0.13
- DKI 0.00
- MACD
- ALLR -0.01
- DKI 0.00
- Stochastic Oscillator
- ALLR 72.97
- DKI 0.00
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About DKI DarkIris Inc. Class A Ordinary Shares
Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.